# LYELL IMMUNOPHARMA INC (LYELXXXX)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/LYELXXXX/

- Reporting holders: 1
- Reported value: $9.7M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Decheng Capital LLC](https://holderbook.com/funds/2010850-decheng-capital-llc/) | $9.7M | 692,050 | 1.3% | 7 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 1 | $9.7M |
| Q1 2026 | 1 | $13.9M |
| Q4 2025 | 1 | $21.3M |
| Q3 2025 | 2 | $10.6M |
| Q2 2025 | 5 | $21.6M |
| Q1 2025 | 109 | $70.9M |
| Q4 2024 | 101 | $83.0M |
| Q3 2024 | 114 | $166.5M |
| Q2 2024 | 115 | $183.3M |
| Q1 2024 | 123 | $282.5M |
| Q4 2023 | 115 | $240.8M |
| Q3 2023 | 103 | $180.1M |